Seraxis to Provide Oral Update on Its Pancreatic Organoid Candidate for Functional Cure of T1D at th

Dr. William Rust will give an oral presentation on Seraxis’ proprietary technology for the production of therapeutic pancreatic organoids from pancreas-derived stem cells, as well as review initial diabetes model data of functional cure of Type 1 Diabetes. Seraxis’ presentation, entitled “Stem-cell Derived Islets fo...

Related Keywords

Germantown ,Maryland ,United States ,Hamburg ,Germany ,Ted Hibben ,William Rust ,Seraxis Inc ,Corporate Development ,European Association For The Study Of Diabetes ,Derived Islets ,Stem Cells Today ,European Association ,Annual Meeting ,Short Oral Event ,Chief Corporate Development ,Contact Information ,Provide Oral Update ,Its Pancreatic Organoid Candidate ,Functional Cure ,